Cabatuan, Jena .
HRN: 22-93-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/21/2023
04/28/2023
PO
500mg
BID
Cervical Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes